Jacobs Levy Equity Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-366,448
| Closed | -$1.2M | – | 1114 |
|
|
2021
Q3 | $1.2M | Buy |
366,448
+29,012
| +9% | +$94.8K | 0.01% | 719 |
|
|
2021
Q2 | $1.42M | Buy |
337,436
+222,504
| +194% | +$939K | 0.01% | 669 |
|
|
2021
Q1 | $574K | Sell |
114,932
-80,868
| -41% | -$404K | ﹤0.01% | 842 |
|
|
2020
Q4 | $2.48M | Sell |
195,800
-1,634
| -0.8% | -$20.7K | 0.02% | 527 |
|
|
2020
Q3 | $1.94M | Sell |
197,434
-33,826
| -15% | -$332K | 0.02% | 526 |
|
|
2020
Q2 | $2.3M | Sell |
231,260
-8,947
| -4% | -$89K | 0.02% | 504 |
|
|
2020
Q1 | $2.12M | Buy |
240,207
+23,295
| +11% | +$206K | 0.03% | 462 |
|
|
2019
Q4 | $2M | Buy |
216,912
+130,612
| +151% | +$1.2M | 0.02% | 543 |
|
|
2019
Q3 | $507K | Buy |
86,300
+47,000
| +120% | +$276K | 0.01% | 718 |
|
|
2019
Q2 | $472K | Buy |
+39,300
| New | +$472K | 0.01% | 748 |
|
|
2017
Q1 | – | Sell |
-58,314
| Closed | -$600K | – | 1032 |
|
|
2016
Q4 | $600K | Buy |
58,314
+26,462
| +83% | +$272K | 0.01% | 643 |
|
|
2016
Q3 | $322K | Buy |
31,852
+5,016
| +19% | +$50.7K | 0.01% | 794 |
|
|
2016
Q2 | $301K | Buy |
26,836
+14,996
| +127% | +$168K | 0.01% | 882 |
|
|
2016
Q1 | $162K | Buy |
+11,840
| New | +$162K | ﹤0.01% | 997 |
|